Filing Details

Accession Number:
0001209191-23-034605
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-06-05 18:32:58
Reporting Period:
2023-06-02
Accepted Time:
2023-06-05 18:32:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1783183 Phathom Pharmaceuticals Inc. PHAT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1363812 Molly Henderson C/O Phathom Pharmaceuticals, Inc.
100 Campus Drive, Suite 102
Florham NJ 07932
Cfo And Cbo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-06-02 1,960 $11.41 68,506 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 339 Indirect By 401(K)
Footnotes
  1. The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 28, 2022.
  2. Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in two transactions at prices 11.41 and 11.5653. The reporting person undertakes to provide the Issuer, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.